FDA Clearance Tracker · P210007-S005
Vivistim System
Last checked: Nov 20, 2026Latest source record: Apr 24, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Apr 24, 2025
Approved
Time to decision
51 days
Received Mar 4, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P210007-S005
- Device name
- Vivistim System
- Applicant
- Mobia Medical, Inc.
- Applicant location
- Austin, TX
- Received
- Mar 4, 2025
- Decided
- Apr 24, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P210007
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Site Change Supplement located at the MN Ops Center, 5155 E. River Rd., Suite 409, Fridley, MN, 55421 for receiving, storage, and shipping of the Vivistim System.
Source documents
Other decisions for Mobia Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Vivistim® SystemBreakthroughPMA
P210007 · Decided Aug 27, 2021 · 178 days after receipt
Device type: Stimulator, autonomic nerve, implanted for stroke rehabilitation (QPY) · Physical Medicine & Rehabilitation
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.